Target intelligence / Profile preview

Aluminium (Al)

Target
Al
Molecular classification
Other
01

Overview

Aluminium is a non-essential trivalent metal cation that lacks a known physiological role in the human body but is ubiquitous in the environment and medical products (Exley, 2011). It is commonly encountered in clinical practice as an active component of antacids, a phosphate binder in renal failure, and an adjuvant in various vaccines to stimulate the immune system (Moraes et al., 2011). Despite its utility, aluminium is a potent neurotoxin and bone toxin, particularly in individuals with compromised renal function who cannot effectively excrete the metal (Yokel, 2002). It interferes with essential biological processes by mimicking other metal ions like iron and calcium, leading to oxidative stress, disrupted enzyme activity, and the formation of amyloid-like aggregates (Walton, 2014). Chronic exposure has been linked to dialysis encephalopathy, osteomalacia, and is a suspected factor in the pathogenesis of Alzheimer's disease (Kawahara & Kato-Negishi, 2011). Therapeutic intervention for aluminium overload typically involves chelation therapy with agents such as deferoxamine, which bind the metal to facilitate its elimination (Yokel, 2002).

Other names
AluminumAl(III)Aluminium(3+)Aluminium ion
02

Mechanism of action

The primary mechanism for drugs targeting aluminium is chelation, where agents like deferoxamine bind to trivalent aluminium ions (Al3+) to form stable, water-soluble complexes that are subsequently excreted by the kidneys or bile (Yokel, 2002).

03

Biological functions

Other
04

Disease associations

Neurodegenerative diseaseOther
05

Safety considerations

NeurotoxicityOsteomalaciaMicrocytic anemiaAccumulation in renal impairment
06

Interacting drugs

Deferoxamine

2 more in the full profile.

07

Biomarkers

Serum aluminium levelsBone aluminium contentDeferoxamine mobilization test

Beyond the preview

Go deeper on Aluminium (Al).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aluminium (Al).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call